Archive Newsletter

  1. 02.25.26 -- FDA's PreCheck Pilot Is Open: What You Need To Know To Apply 2/25/2026
    02/25/26
  2. 02.24.26 -- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact 2/24/2026
    02/24/26
  3. 02.24.26 -- STREAM Edition: CGT Regulation In 2026 Moves Toward Disciplined Flexibility And Higher Standards 2/24/2026

    02/24/26 Cell & Gene Newsletter

  4. 02.23.26 -- Mastering EU GMP Annex 1: Packaging, Performance, And Contamination Control 2/23/2026

    02/23/26 Cell & Gene Newsletter

  5. 02.23.26 -- Ready to design a scalable, cost optimized viral vector workflow? 2/23/2026

    02/23/26 Cell & Gene Newsletter

  6. 02.23.26 -- Ensuring The Raw Material Data Package Supports Regulatory Filings 2/23/2026
    02/23/26 Cell & Gene Newsletter
  7. 02.20.26 -- Deciding When Research Grade Raw Materials Are Sufficient 2/20/2026
    02/20/26
  8. 02.19.26 -- Advancing Your Cell and Gene Therapy Journey 2/19/2026
    02/19/26 Cell & Gene Newsletter
  9. 02.19.26 -- Why In Vivo Therapies Fail When We Treat Them Like Ex Vivo Ones 2/19/2026
    02/19/26 Cell & Gene Newsletter
  10. 02.18.26 -- Specialized Fill/Finish For Advanced Therapies 2/18/2026
    02/18/26 Cell & Gene Newsletter